Sun Pharma - Read all the latest news headline updates on Sun Pharma. Get all the Sun Pharma breaking news updates, videos, photostories and more at Business Standard.
Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...
Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter
A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...
As part of the association, Sun Pharma's logo will feature on the front of RCB's playing jersey, the official green kit and training apparel ...
Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.
Indian pharma leaders emphasize the need for innovation at scale, leveraging AI and collaborations to overcome industry ...
U.S. inspectors have found new breakdowns at a Sun Pharmaceuticals plant in India that produces medications for U.S. customers, ProPublica reported July 16. The FDA found the factory failed to ...
Sun Pharmaceuticals’ drug manufacturing plant in Gujarat, India, received an import alert from the FDA Dec. 7, which could threaten the drugmakers’ ability to ship drugs to the U.S. The regulatory ...
Sun Pharmaceutical Industries was hit with a patent infringement lawsuit on July 9 in New Jersey District Court over its attempt to market generic versions of the antipsychotic drug Invega Sustenna.
Pharma giant and 30-scrip basket stock Sun Pharma has underperformed over the past year, with a decline of 10 per cent in the last 12 months and 13 per cent year-to-date (YTD). In contrast, the ...
Sun Pharma's high-growth global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's ...
Sun Pharma share price declined more than 4% on Friday after the drug major reported its Q4 results. Sun Pharma shares fell as much as 4.86% to ₹1,636.30 apiece on the BSE. Sun Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results